Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Early Successful Readout Of Tarceva Study In A Distinct Form Of Lung Cancer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2485673" data-attributes="member: 124445"><p>Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint...<a href="http://feedads.g.doubleclick.net/~a/Un-kg27Wg9nzcHPC1khDKZ2EZyE/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/Un-kg27Wg9nzcHPC1khDKZ2EZyE/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/Un-kg27Wg9nzcHPC1khDKZ2EZyE/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/Un-kg27Wg9nzcHPC1khDKZ2EZyE/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/XJWM_35fpfs" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/XJWM_35fpfs/3QBS" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2485673, member: 124445"] Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint...[URL="http://feedads.g.doubleclick.net/~a/Un-kg27Wg9nzcHPC1khDKZ2EZyE/0/da"][IMG]http://feedads.g.doubleclick.net/~a/Un-kg27Wg9nzcHPC1khDKZ2EZyE/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/Un-kg27Wg9nzcHPC1khDKZ2EZyE/1/da"][IMG]http://feedads.g.doubleclick.net/~a/Un-kg27Wg9nzcHPC1khDKZ2EZyE/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/XJWM_35fpfs[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/XJWM_35fpfs/3QBS]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top